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Activity-dependent neurite outgrowth is a highly complex, regulated process with
important implications for neuronal circuit remodeling in development as well as in
seizure-induced sprouting in epilepsy. Recent work has linked outgrowth to collapsin
response mediator protein 2 (CRMP2), an intracellular phosphoprotein originally identified
as axon guidance and growth cone collapse protein. The neurite outgrowth promoting
function of CRMP2 is regulated by its phosphorylation state. In this study, depolarization
(potassium chloride)-driven activity increased the level of active CRMP2 by decreasing
its phosphorylation by GSK3β via a reduction in priming by Cdk5. To determine the
contribution of CRMP2 in activity-driven neurite outgrowth, we screened a limited
set of compounds for their ability to reduce neurite outgrowth but not modify
voltage-gated sodium channel (VGSC) biophysical properties. This led to the identification
of (S)-lacosamide ((S)-LCM), a stereoisomer of the clinically used antiepileptic drug
(R)-LCM (Vimpat®), as a novel tool for preferentially targeting CRMP2-mediated neurite
outgrowth. Whereas (S)-LCM was ineffective in targeting VGSCs, the presumptive
pharmacological targets of (R)-LCM, (S)-LCM was more efficient than (R)-LCM in
subverting neurite outgrowth. Biomolecular interaction analyses revealed that (S)-LCM
bound to wildtype CRMP2 with low micromolar affinity, similar to (R)-LCM. Through the
use of this novel tool, the activity-dependent increase in neurite outgrowth observed
following depolarization was characterized to be reliant on CRMP2 function. Knockdown
of CRMP2 by siRNA in cortical neurons resulted in reduced CRMP2-dependent neurite
outgrowth; incubation with (S)-LCM phenocopied this effect. Other CRMP2-mediated
processes were unaffected. (S)-LCM subverted neurite outgrowth not by affecting the
canonical CRMP2-tubulin association but rather by impairing the ability of CRMP2 to
promote tubulin polymerization, events that are perfunctory for neurite outgrowth. Taken
together, these results suggest that changes in the phosphorylation state of CRMP2 are
a major contributing factor in activity-dependent regulation of neurite outgrowth.
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INTRODUCTION
Neurite outgrowth is a highly regulated, progressive process,
responding to a myriad of intrinsic as well as external cues, such
Abbreviations: CRMP2, collapsin response mediator protein 2; DIV, days in vitro;
E19, embryonic day 19; ELISA, enzyme-linked immunosorbent assay; EGFP,
green fluorescent protein; LCM, lacosamide; VGSC, voltage-gated sodium chan-
nel; GSK3β, glycogen synthase kinase 3 β; Cdk5, cyclin-dependent kinase 5; cAMP,
cyclic adenosinemonophosphate; RhoK, Rho kinase; CaMKII, calcium/calmodulin
dependent protein kinase II; PP1/2A, protein phosphatase 1/2A; MST, microscale
thermophoresis.
as network activity. Activity-dependent outgrowth has long been
attributed to focal changes in intracellular calcium concentra-
tion (Cohan and Kater, 1986; Connor, 1986; Fields et al., 1990;
Schilling et al., 1991). The growth promoting aspect of activity is
constrained within a small range of calcium concentrations, out-
side of which retraction and growth cone collapse can occur, sug-
gesting the process is tightly regulated (Cohan and Kater, 1986;
Kater et al., 1988; van Pelt et al., 1996). Such regulation allows for
a reciprocal relationship between outgrowth and network con-
nectivity (Van Ooyen et al., 1995). A better understanding of
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activity-dependent changes in synaptic organization may provide
essential insight into pathological processes involving abnormally
high levels of neuronal activity, such as epilepsy.
Mechanistic studies have suggested that the rise in intracel-
lular calcium necessary to promote growth may be attributed
to calcium influx through N-methyl-D-aspartate receptors,
L-type voltage-gated calcium channels, or both (Kocsis et al.,
1994; Wayman et al., 2006). Regardless of the initial route
of calcium entry, preventing its secondary mobilization from
intracellular stores abolishes the growth promoting effects of
depolarization-induced activity (Kocsis et al., 1994). Other than
strict calcium dependence, the specific mechanisms underlying
activity-dependent outgrowth are relatively unknown. Second
messenger systems, especially those responsive to changes in
intracellular calcium such as cAMP, have been suggested to play
a role (Mattson et al., 1988). Additionally, inhibitors of tran-
scription have also been used to suggest that transcription—most
likely of growth promoting genes—may be an important step
linking activity to cytoskeletal dynamics (Solem et al., 1995).
Further studies also suggest the importance of kinase cascades
(Solem et al., 1995; Wayman et al., 2006). Recently, activity-
induced outgrowth in cerebellar granule cells was attributed to
changes in the kinase GSK3β and its substrate, collapsin response
mediator protein 2 (CRMP2) (Tan et al., 2013). CRMP2 is an
intracellular phosphoprotein originally identified for coordinat-
ing axon guidance and growth cone collapse (Goshima et al.,
1995). More recently, numerous other functions for CRMP2
have been identified, implicating CRMP2 in a variety of neu-
ropathologies (for review see Hensley et al., 2011; Khanna et al.,
2012).
Of particular importance to our investigations is the abil-
ity of CRMP2 to mediate neurite outgrowth via transport and
stabilization of tubulin dimers (Fukata et al., 2002) as well as
enhancement of tubulin’s intrinsic GTPase activity (Chae et al.,
2009). In regards to its outgrowth-promoting function, the activ-
ity of CRMP2 is regulated by its phosphorylation state. In the
unphosphorylated state CRMP2 is considered active and thereby
growth-promoting, however, upon phosphorylation by glyco-
gen synthase kinase 3β (GSK3β), cyclin dependent kinase 5
(Cdk5), Rho kinase (RhoK), Ca2+ /calmodulin-dependent pro-
tein kinase II (CaMKII), or Fyn kinases, CRMP2 is rendered
inactive (Arimura et al., 2000, 2005; Brown et al., 2004; Cole
et al., 2004, 2006; Uchida et al., 2005, 2009; Yoshimura et al., 2005;
Hou et al., 2009). Along those same lines, dephosphorylation by
the protein phosphatases PP2A and PP1 promotes neurite out-
growth (Zhu et al., 2010; Astle et al., 2011). Elegant studies by the
Ohshima and Goshima groups suggest that changes in the phos-
phorylation state of CRMP2 may allow for dynamic regulation of
outgrowth and branching patterns, as phosphorylation by Cdk5
is necessary for proper bifurcation of CA1 apical dendrites as well
as organization of dendritic fields (Yamashita et al., 2012; Niisato
et al., 2013). In fact, the ability of CRMP2 to coordinate axon
guidance/growth cone collapse by Sema3A relies on phosphory-
lation (Arimura et al., 2005; Uchida et al., 2005, 2009). However,
very little is known about the regulation of CRMP2 phospho-
rylation following neuronal activity. As post-translational mod-
ifications serve to regulate numerous processes throughout the
nervous system, including those that are activity-dependent, here
we tested the hypothesis that changes in CRMP2 phosphoryla-
tion may account for the changes in neurite outgrowth observed
following neuronal activity.
In this study we demonstrate that neuronal activity induced
by KCl depolarization in cortical neurons led to decreased GSK3β
phosphorylation (residues T509/T514) of CRMP2, which was
attributed to reduced priming by Cdk5 (residue S522 of CRMP2).
The loss of phosphorylation directly translated into an increase
in the amount of CRMP2/tubulin binding, concomitant with
an increase in neurite outgrowth. Through the use of a novel
small molecule identified herein, we were able to demonstrate
an inhibition in CRMP2-facilitated tubulin polymerization with-
out a change in CRMP2-tubulin binding. Consequently, it was
determined that activity-driven neurite outgrowth was prevented
through inhibition of CRMP2-mediated neurite outgrowth.
MATERIALS AND METHODS
MATERIALS
All reagents were purchased from Sigma (St. Louis, MO, USA)
unless otherwise indicated. (S)-LCM, a functionalized amino
acid, and some of its derivatives were provided by the laboratory
of Dr. Harold Kohn, University of North Caroline, Chapel Hill.
A 100mM solution was made up in dimethylsulfoxide (DMSO)
and stored in small aliquots at −20◦C. Microscale thermophore-
sis (MST) labeling solutions and binding buffers were purchased
from Nanotemper (München, Germany).
PRIMARY CORTICAL NEURON CULTURE
Primary cortical neurons were prepared from embryonic day
18–19 Sprague–Dawley rats as described (Brittain et al., 2009,
2011a; Wang et al., 2010a) with some modifications. Briefly,
cortices were dissected and cell suspensions were plated onto
poly-D Lysine-coated glass coverslips. 5-fluor-2′-deoxyuridine
(1.5μg/mL) was added 48 h after plating to reduce the num-
ber of non-neuronal cells. The cultures contain ∼95% neurons
(both excitatory and inhibitory) with the remaining 5% com-
prised mostly of astrocytes and the occasional microglia. All
procedures were in compliance with Institutional Animal Care
andUse Committees of the Indiana University School ofMedicine
and the College of Medicine at the University of Arizona as well
as with ARRIVE guidelines.
IMMUNOBLOT ANALYSIS
Lysates were made from cultured cortical neurons at 6 DIV in
RIPA buffer containing protease and phosphatase inhibitor cock-
tails as previously described (Brittain et al., 2009). Samples were
boiled in Laemmli sample buffer and separated by electrophore-
sis on SDS-polyacrylamide gels. Proteins were transferred to
polyvinylidene difluoride membranes and blocked at room tem-
perature for 1 h and incubated in primary antibodies CRMP2
(Cat# C2993, Sigma, St. Louis, MO), CRMP2 pThr509/Thr514
(Cat# PB-043, Kinasource, Dundee, Scotland, UK), CRMP2
pSer522 (Cat# CP2191, ECM Biosciences, Versailles, KY), GSK3β
pSer9 (Cat# 5558, Cell Signaling, Danvers, MA), Cdk5 (Cat#
2506, Cell Signaling, Danvers, MA), p35 (Cat# 2680, Cell
Signaling, Danvers, MA), GSK3β (Cat# 9832, Cell Signaling,
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Danvers, MA), or Tubulin (Cat# G712A, Promega, Madison,
WI) overnight at 4◦C. Following incubation in horseradish per-
oxidase conjugated secondary antibodies, blots were probed
with enhanced chemiluminescence Western blotting substrate
(Thermo Scientific, Waltham, MA) before exposure to photo-
graphic film. Films were scanned, digitized, and quantified using
Un-Scan-It gel version 6.1 scanning software (Silk Scientific Inc,
Orem, UT).
NEURITE OUTGROWTH IMAGING AND ANALYSIS
Primary cortical neurons were transfected via lipofectamine 2000
(Invitrogen) with enhanced green fluorescent protein (EGFP) at
4 DIV and incubated 24 h in 300μM (R)-LCM, LCM derivatives,
or vehicle before imaging with ImageXpress Micro (Molecular
Devices, Sunyvale, CA). The overexpression of EGFP allowed
for visualization of a small percentage of neurons while main-
taining optimal cell densities required for survival. To compare
the effects of (S)-LCM and CRMP2siRNA primary cortical neu-
rons were transfected via lipofectamine 2000 with EGFP, con-
trol siRNA + EGFP, or CRMP2-siRNA + EGFP at 4 DIV and
incubated with 200μM (S)-LCM for 24 h before imaging with
ImageXpress Micro. Analysis of neurite outgrowth was completed
using a neurite outgrowth analysis protocol with the MetaXpress
software (Molecular Devices, Sunnyvale, CA). Non-neuronal
cells were easily identifiable and excluded based on morphol-
ogy. Neuronal cell soma and processes are detected by defining
separate size and fluorescence intensity threshold parameters.
Maximum width and minimum area parameters for determining
somas were set to 50 and 300μm2, respectively. For identify-
ing processes, maximum width and minimum length parameters
were set to 8 and 3μm, respectively. Cells were excluded if they
were determined not to be neurons based on morphology, if
processes extended beyond the image field, or if no processes
were longer than 50μm. The following parameters are recorded
and summarized into a final “total outgrowth” parameter: num-
ber of processes, number of branches, mean process length, and
maximum process length.
PURIFICATION OF RECOMBINANT CRMP2 AND CRMP25ALA PROTEINS
A CRMP2-GST construct containing 5 amino acids in pre-
dicted LCM-binding regions of CRMP2 mutated to alanine
(CRMP25ALAGST; G360, S363, K418, I420, and P443) was
generated by subcloning the mutation containing portion of
CRMP25ALA-EGFP into wild-type CRMP2-GST (using restric-
tion enzymes RsrII and BglII). Both wild-type andmutant recom-
binant proteins were purified exactly as described (Brittain et al.,
2009; Wang et al., 2010b).
MICROSCALE THERMOPHORESIS (MST) BINDING ANALYSIS
MST, the directed movement of molecules in optically generated
microscopic temperature gradients, permits an immobilization-
free fluorescence methodology for the analysis of biomolecular
interaction (Wienken et al., 2010; van den Bogaart et al., 2012).
The thermophoretic movement is determined by the entropy
of the hydration shell around the labeled molecule. The sol-
vation entropy and the hydration shell of the macromolecules
provide the driving force for the flow, and any change of the
hydration shell of biomolecules due to changes in their pri-
mary, secondary, tertiary and/or quaternary structure affects their
thermophoretic mobility and can be used to determine binding
affinities and enzymatic activities with high accuracy and sen-
sitivity. A microscopic temperature gradient is generated by an
infrared laser. In a typical MST-experiment the concentration
of the labeled molecule is kept constant while the concentra-
tion of the unlabeled interaction partner is varied. NT647-labeled
CRMP2 or CRMP25ALA (500 nM final) was incubated for 10min
at room temperature in the dark with increasing concentra-
tions of (S)-LCM. Thermophoresis analysis was performed on a
NanoTemper Monolith NT.115 instrument (25% LED; 25% IR-
laser power). The MST curves were fitted with a Hill method
using Origin 8.5 software to obtain apparent Kd values for
binding interactions.
ELISA-BASED CRMP2-TUBULIN BINDING ASSAY
The 96-well plates (Nunc Maxisorp, Thermo Scientific) were
coated with tubulin (200 ng/well, Cytoskeleton Inc.) and incu-
bated at room temperature overnight. The following day the
plates were washed and blocked with 3% BSA to minimize
non-specific adsorptive binding to the plates. Escalating con-
centrations of CRMP2 were added to the plates. As a nega-
tive control, some wells received escalating concentrations of
CRMP2 which was denatured by heating at 95◦C for 5min.
The plates were incubated at room temperature with shak-
ing for 2 h. The plates were then washed with PBS contain-
ing 0.5% Tween-20 to eliminate unbound CRMP2. The bound
CRMP2 was detected by CRMP2 primary antibody (150 ng/ml,
Sigma) followed by HRP-conjugated secondary antibody (GE
Healthcare). Tetramethylbenzidine (R&D Systems) was used as
the colorimetric substrate. The optical density of each well was
determined immediately, using a microplate reader (Multiskan
Ascent, Thermo) set to 450 nm with a correction wavelength
of 570 nm. Data was analyzed by non-linear regression analysis
using GraphPad Prism5 (Graph Pad, San Diego, CA).
To determine the effect of (S)-LCM on CRMP2-tubulin bind-
ing, 96-well plates were coated with tubulin and incubated
overnight. The following day the plates were washed and blocked
with 3% BSA to minimize non-specific adsorptive binding to the
plate. After the wash all the wells received 1μM of CRMP2 and
none or escalating concentrations of (S)-LCM. The plates were
then incubated at room temperature with shaking for 2 h. This
was followed with washes to eliminate the unbound CRMP2.
CRMP2 bound to the plates was detected using the method
described above.
A cell lysate based ELISA was performed as described above,
with some modifications. In tubulin-coated 96-well plates, lysates
from cortical cells treated with vehicle, KCl, (S)-LCM, or KCl +
(S)-LCM were added. Next, the plates were incubated at room
temperature with shaking for 2 h. The plates were then washed to
eliminate the unbound proteins. The bound CRMP2was detected
as described above. The optical density of each well was deter-
mined immediately, using a microplate reader set to 450 nm with
a correction wavelength of 570 nm. The optical densities were
normalized to the amount of protein in each sample. Data was
analyzed as described earlier.
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TURBIDIMETRIC ASSAY FOR TUBULIN POLYMERIZATION
Polymerization of tubulin was performed as previously described
(Chae et al., 2009; Wilson et al., 2012a) with modifications.
Polymerization was performed in 0.1M G-PEM buffer (1mM
GTP, 80mM PIPES, 1mM EGTA, 1mM MgCl2, pH 7.0), 1mM
Na-GTP (Sigma), and 2mg/ml tubulin (Cytoskeleton, Inc).
CRMP2 proteins (0.2μM) as well as 3μM of (R)-LCM, (S)-LCM
or 0.01% DMSO were added to the samples and pipetted onto
a 96-well plate at 4◦C. Following a 30min incubation on ice,
turbidity changes were assessed at 412 nm using a Synergy™ 2
Multi-Detection Microplate Reader (BioTek Instruments, Inc.,
San Diego, CA) which had previously been pre-warmed to 37◦C.
Absorbances were measured over time and compared to back-
ground samples which contained only buffer + GTP.
WHOLE-CELL PATCH-CLAMP RECORDINGS
Whole-cell voltage recordings were performed at room tem-
perature on primary cultured cortical neurons using an EPC
10 Amplifier (HEKA Electronics, Germany). Electrodes were
pulled from thin-walled borosilicate glass capillaries (Warner
Instruments, Hamden, CT) with a P-97 electrode puller (Sutter
Instrument, Novato, CA) such that the final electrode resistances
were 2–3M when filled with internal solutions. The internal
solution for recording Na+ currents contained (in mM): 110
CsCl, 5 MgSO4, 10 EGTA, 4 ATP Na2, and 25 HEPES (pH 7.2,
290-310 mOsmo/L). For recording Na+ currents, the external
solution contained (in mM): 100 NaCl, 10 tetraethylammonium
chloride (TEA-Cl), 1 CaCl2, 1 CdCl2, 1 MgCl2, 10 D-glucose,
4 4-AP, 0.1 NiCl2, 10 HEPES (pH 7.3, 310-315 mOsm/L). Whole-
cell capacitance and series resistance were compensated with the
amplifier (70–80%). Cells were considered only when the seal
resistance was more than 1G and the series resistance was less
than 10M. Linear leak currents were digitally subtracted by P/4.
Neurons were held at −100mV, conditioned to potentials rang-
ing from −10 to +20mV (in +10mV increments) for 5 s, and
then fast-inactivated channels were allowed to recover for 150ms
at a hyperpolarized pulse to −120mV, and the fraction of chan-
nels available was tested by a single depolarizing pulse, to 0mV,
for 15ms.
KNOCKDOWN OF CRMP2 EXPRESSION BY siRNA
Validated short interfering RNAs (siRNAs) against the rat CRMP2
(5′- ACTCCTTCCTCGTGTACAT-3′) sequence (Brittain et al.,
2009) and controls (scrambled sequence with approximately the
same GC percentage but no sequence homology) were used for
CRMP2 knockdown (Invitrogen) in cortical neurons as described
(Brittain et al., 2009; Chi et al., 2009; Wilson et al., 2012a).
Cells were incubated for 2 days with vector- or scramble siRNA
(250 nM) and extent of knockdown was assessed via immunoblot
analysis. As previously reported (Chi et al., 2009; Brustovetsky
et al., 2014), we observed ∼90% knockdown of CRMP2 com-
pared to scramble siRNA (data not shown).
ACTIVITY-DEPENDENT NEURITE OUTGROWTH IMAGING
For analysis of activity-dependent outgrowth, neurons were incu-
bated in vehicle (<0.01% DMSO), 25mM KCl, 200μM (S)-
LCM, or 200μM (S)-LCM + 25mM KCl for 96 h beginning at
2DIV. Media was changed at 4 DIV, maintaining KCl levels at
25mM, at which time neurons were also transfected with EGFP
(4 DIV). EGFP-expressing cells were then imaged at 6 DIV. The
use of 25mM KCl is consistent with previous work reporting
the involvement of CRMP2 in activity-dependent outgrowth (Tan
et al., 2013). Analysis of neurite outgrowth was completed using a
neurite outgrowth analysis protocol with theMetaXpress software
(Molecular Devices, Sunnyvale, CA).
DATA ANALYSIS
All data points are shown as mean ± s.e.m. Statistical differences
between control and experimental conditions were determined
by using ANOVA with a Dunnett’s or Tukey’s post-hoc test or a
Student’s t-test when comparing only two conditions. Values of
p < 0.05 were judged to be statistically significant.
RESULTS
MODERATE ACTIVITY REDUCES CRMP2 PHOSPHORYLATION BY GSK3β
WITHOUT AFFECTING KINASE ACTIVITY
CRMP2 has recently been suggested as a potential mediator of
activity-dependent neurite outgrowth in cerebellar granule neu-
rons (Tan et al., 2013). Unlike other central neurons, cerebellar
granule cells require slightly depolarizing conditions for survival
in vitro. Therefore, it is difficult to generalize this finding to other
neuronal populations within the central nervous system. As such,
it is not known if CRMP2 is involved in outgrowth induced by
depolarization in neurons where it is not necessary for survival.
As the ability of CRMP2 to enhance neurite outgrowth is highly
dependent upon its phosphorylation state (for review see Khanna
et al., 2012), Western blot analysis was used to determine the level
of GSK3β-phosphorylated CRMP2 following acute (30min) and
chronic exposure to KCl (96 h) treatment (Figure 1A). The 96 h
KCl treatment was chosen as it reproducibly increased neurite
outgrowth. Additionally, as it was unknown how long any bio-
chemical changes, such as phosphorylation, would be sustained,
a more acute (30min) treatment was also used. Treatment with
25mM KCl reduced the level of GSK3β-phosphorylated CRMP2
by ∼60.8% (acute) and ∼54.8% (chronic) compared to con-
trol (p < 0.05), while total CRMP2 expression did not change
(Figures 1B–D). Therefore, exposure to KCl leads to increased
levels of active, unphosphorylated CRMP2.
Similar to CRMP2, GSK3β activity is regulated by changes
in phosphorylation state, whereby phosphorylation at GSK3β
Ser9 is sufficient to inhibit its kinase function (Cross et al.,
1995). To determine if the decrease in CRMP2 phosphoryla-
tion induced by KCl is due to decreased levels of GSK3β activ-
ity, the amount of Ser9-phosphorylated GSK3β was measured
following KCl exposure. Interestingly, neither Ser9 phospho-
rylation nor total expression of GSK3β was affected by KCl
exposure (Figures 1E–H), suggesting that the decrease in GSK3β-
phosphorylated CRMP2 is not attributed to a change in GSK3β
expression or activity.
MODERATE ACTIVITY REDUCES CDK5 PRIMING OF CRMP2
In the case of CRMP2, substrate recognition by GSK3β
first requires phosphorylation by Cdk5 at a downstream site
(Ser522), which “primes” the protein for subsequent GSK3β
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FIGURE 1 | KCl-induced activity decreases GSK3β phosphorylation of
CRMP2 without changing GSK3β activity or expression. (A) Top: Timeline
of experimental procedures. Bottom: Schematic of GSK3β and Cdk5
phosphorylation sites within the rat CRMP2 sequence. Numbers represent
amino acid residues within the CRMP2 sequence. Representative
immunoblots of GSK3β-phosphorylated CRMP2 (CRMP2 pThr509/pThr514),
total CRMP2, and βIII-tubulin (B), inactivated Ser9-phosphorylated GSK3β and
βIII-tubulin (E), and total GSK3β and βIII-tubulin (G) from naïve cortical neurons
compared to those exposed to KCl for 30min or 96 h. Summary of the relative
levels of the indicated proteins (C,D,F,H). Expression of GSK3β-phosphorylated
CRMP2 (CRMP2 pThr509/pThr514) is decreased following 30min or 96 h
exposure to KCl (C) whereas total CRMP2 expression was not affected by KCl
exposures (D) (∗p < 0.05 compared to control; One-Way ANOVA, Tukey’s
post-hoc analysis) (n = 4). KCl treatment did not alter phosphorylation of
GSK3β (F) nor total GSK3β expression (H) did not change following 30min or
96 h KCl treatment (One-Way ANOVA, Tukey’s post-hoc analysis) (n = 5).
phosphorylation (Cole et al., 2006) (see Figure 2B). Therefore,
Western blot analysis of Cdk5-phosphorylated CRMP2 was
used to determine if the KCl-induced decrease in GSKβ phos-
phorylation is due to a reduction in Cdk5 priming. Both
acute and chronic exposure to KCl (Figure 2A) decreased
the level of Cdk5-phosphorylated CRMP2 in a time depen-
dent manner by ∼44.8% (acute) and ∼84.9% (chronic) com-
pared to control (p < 0.05) (Figures 2C,D), suggesting that the
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FIGURE 2 | KCl-induced activity decreases Cdk5-phosphorylated
CRMP2. (A) Timeline of experimental procedures. (B) Schematic of GSK3β
and Cdk5 phosphorylation sites within the rat CRMP2 sequence. Numbers
represent amino acid residues within the CRMP2 sequence. (C)
Representative immunoblots of Cdk5-phosphorylated CRMP2 (CRMP2
pSer522) and βIII-tubulin from naïve cortical neurons compared to those
exposed to KCl for 30min or 96 h. (D) KCl exposure lead to a
time-dependent decrease in the level of Cdk5-phosphorylated CRMP2
(CRMP2 pSer522) (∗p < 0.05 compared to control and #p < 0.05 compared
to 30min KCl treatment; One-Way ANOVA, Tukey’s post-hoc analysis;
n = 5).
activity-dependent decrease in GSK3β-phosphorylated CRMP2
can be attributed to decreased levels of Cdk5-primed CRMP2.
The loss of Cdk5-phopshorylated CRMP2 cannot be
attributed to changes in kinase expression as levels of Cdk5
remained consistent following KCl exposure (0.0159 ± 0.0012)
compared to control (0.0156± 0.0004) (p > 0.05) (Supplemental
Figure 1). Aside from expression level, Cdk5 activity is primarily
determined by the level of its cofactor p35 (Lee et al., 1996;
Zhu et al., 2005). However, Western blot analyses reveals that
expression of p35 was also not altered following KCl exposure
(0.0113 ± 0.0014) compared to control (0.0110 ± 0.0009)
(p > 0.05), suggesting the loss of Cdk5-phosphorylated CRMP2
is independent of the expression of Cdk5 or its cofactor.
IDENTIFICATION OF AN (R)-LCM DERIVATIVE FOR THE STUDY OF
CRMP2-MEDIATED NEURITE OUTGROWTH
The aforementioned data suggest that chronic depolarization
via KCl leads to a prolonged loss of both GSK3β- and Cdk5-
phosphorylated CRMP2. As phosphorylation at these sites
is canonically known to inactivate the outgrowth-promoting
function of CRMP2 (Brown et al., 2004; Cole et al., 2004,
2006; Uchida et al., 2005; Yoshimura et al., 2005), the
KCl-induced loss of phosphorylation should translate to an over-
all increase in CRMP2 activity. However, to determine how
the increase in the proportion of active CRMP2 relates to
KCl-facilitated neurite outgrowth, it is necessary to preferen-
tially target CRMP2 function. Previously, we demonstrated that
the novel anti-epileptic drug (2R)-2-(acetylamino)-N-benzyl-
3-methoxypropanamide [(R)-LCM, tradename Vimpat®] could
directly impair the ability of CRMP2 to enhance neurite
outgrowth (Wilson et al., 2012a). (R)-LCM purportedly targets
steady-state gating kinetics by selectively enhancing sodium chan-
nel slow inactivation (Zhu et al., 2005). However, its additional
actions on the voltage gated sodium channel (VGSC) render it
unsuitable for use as a tool in investigation of CRMP2 func-
tions (Errington et al., 2008; Sheets et al., 2008). Therefore,
derivatives of (R)-LCM that were unable to impact VGSC slow-
inactivation were screened for their ability to inhibit neurite
outgrowth (Table 1). Neurite outgrowth was measured from
EGFP-transfected primary cultured cortical neurons using the
ImageXpress Micro and MetaXpress software systems (Molecular
Devices) following overnight exposure to each derivative. This
analysis combines the following measurements: number of pri-
mary neurites, number of branches, mean process length, and
maximum process length to determine a summary of total
outgrowth per cell. The only derivative identified to impact
neurite outgrowth was (S)-LCM, which reduced neurite out-
growth by ∼35% compared to vehicle (<0.01% DMSO). (R)-
LCM was originally determined to be stereoselective, as the
(S)-isomer requires much higher concentrations to halt seizure
activity in vivo (Andurkar et al., 1999; LeTiran et al., 2001).
This data suggests that (S)-LCM may retain the ability to target
CRMP2.
BINDING OF (S)-LCM TOWILDTYPE, BUT NOT MUTANT, CRMP2
MST was used to determine if (S)-LCM could interact with puri-
fied CRMP2. Using an infrared laser, precise microscopic temper-
ature gradients are generated within thin glass capillaries filled
with a fluorescently labeled protein sample (i.e., CRMP2), and
the atomistic movement of molecules along these temperature
gradients is monitored in the presence of increasing concentra-
tions of an unlabeled binding partner (S)-LCM (Figures 3A,B).
As the concentration of (S)-LCM increased, it bound to CRMP2
thermodiffusing out of the heated infrared spot, resulting in a
change in the MST signal and providing a readout of the bind-
ing between the CRMP2 and (S)-LCM. NT647-labeled CRMP2
protein was incubated with varying concentrations of (S)-LCM
(0.006–100μM) and apparent Kd values were obtained by fit-
ting curves using the Hill method. MST experiments revealed
that (S)-LCM bound to WT CRMP2 with an apparent Kd of
1.5 ± 0.01μM (Figures 3C,D). Importantly, Kd of (S)-LCM
is similar to what is observed for (R)-LCM in this assay (1.0
± 0.04μM; Figure 3D) (Wilson and Khanna, 2014). We had
previously identified 5 key residues on CRMP2, essential for
coordinating (R)-LCM binding and mutated them to alanines
to create CRMP25ALA, whose function mimics that of wildtype
CRMP2, yet is not impaired by the presence of (R)-LCM (Wang
et al., 2010b; Wilson et al., 2012a) (Figure 3E). MST experi-
ments revealed that (S)-LCMdid not interact with NT647-labeled
CRMP25ALA (Figures 3F,G), suggesting that the same binding
pocket is necessary for coordinating both (R)- and (S)-LCM
binding.
(S)-LCM IMPAIRS THE ABILITY OF CRMP2 TO ENHANCE TUBULIN
POLYMERIZATION WITHOUT ALTERING TUBULIN BINDING OR VGSC
SLOW-INACTIVATION
It was previously determined that inhibition of CRMP2-mediated
neurite outgrowth by (R)-LCM was mediated, not through
Frontiers in Cellular Neuroscience www.frontiersin.org July 2014 | Volume 8 | Article 196 | 6
Wilson et al. CRMP2 phosphorylation and neurite outgrowth
Table 1 | Comparison of the ability of lacosamide derivatives to affect VGSC and CRMP2 function.
Compound Structure Slow inactivation IC50 (μM)a Total outgrowth (% of vehicle)b
(R)-LCM 85 81.6 ± 3.7*
(S)-LCM >1000 66.2 ± 5.9*
Derivative 1 >2400 95.8 ± 4.3
Derivative 2 >1000 98.0 ± 4.5
aSlow inactivation IC50 values were obtained from previous reports (Brittain et al., 2009; Sun et al., 2010).
bTotal outgrowth represents outgrowth following a 24 h incubation in 300μM of each compound. For ease of comparison, values were normalized to vehicle.
(*p < 0.05 vs. vehicle) (Student’s t-test) (values represent mean ± s.e.m.) (n = 263–394 cells from 8 separate culture wells).
attenuation of tubulin binding, but by impairing the ability of
CRMP2 to enhance tubulin polymerization (Wilson et al., 2012a).
To ensure that (S)-LCM functions in a similar manner, an ELISA-
based competition assay was used to determine the ability of
CRMP2 to bind tubulin in the presence of increasing concentra-
tions of (S)-LCM. Similar to what was previously observed for
(R)-LCM, binding of CRMP2 and tubulin was not impacted by as
much as 1mM (S)-LCM (Figure 4).
Subsequently, the ability of CRMP2 to enhance tubulin
polymerization in the presence of (S)-LCM was examined via
turbidimetric assay. Based on the principle that light is scattered
by microtubules to an extent that is proportional to the concen-
tration of microtubule polymer, this assay determines the extent
of tubulin polymerization by measuring changes in absorbance.
Consistent with previous results (Wilson et al., 2012a), the
addition of 200 nM recombinant CRMP2 protein dramatically
enhanced tubulin polymerization by ∼2.8-fold as demonstrated
by area under the curve measurements compared to tubulin
alone (p < 0.05) (Figures 5A,B). Similar to what is observed for
(R)-LCM, the ability of CRMP2 to enhance tubulin polymeriza-
tion was impaired by ∼44.0% by as little as 3μM (S)-LCM (p <
0.05) (Figure 5B). Additionally, FM4-64 labeling revealed that
(S)-LCM does not impact synaptic bouton size—a phenomenon
regulated by CRMP2 (Supplemental Figure 2).
To ensure that (S)-LCM is unable to alter VGSC function at
concentrations well above those required for CRMP2 binding,
whole cell recordings were used tomeasure levels of slow inactiva-
tion (Figure 6A). Neither acute nor chronic (24 h) administration
of 300μM (S)-LCM altered the onset or extent of slow inactiva-
tion (Figures 6B,D). This concentration was chosen as it greatly
surpasses those used for subsequent experiments.
(S)-LCM PHENOCOPIES THE EFFECT OF CRMP2 siRNA ON NEURITE
OUTGROWTH
Having demonstrated that (S)-LCM interacts with CRMP2, we
next investigated the possible effect of this interaction on CRMP2
function. If (S)-LCM acts to inhibit CRMP2-mediated neurite
outgrowth, then its action should mimic the phenotype bestowed
by CRMP2 siRNAwithout the off-target effects on other CRMP2-
dependent signaling pathways. Consequently, neurite outgrowth
was measured from EGFP-transfected primary cultured cortical
neurons using the ImageXpress Micro and MetaXpress software
systems (Molecular Devices). Consistent with previous reports
(Wilson et al., 2012a), siRNA knockdown of CRMP2 led to
a ∼37% decrease in total outgrowth (62.6 ± 4.5) compared to
control (100 ± 6.6) (see Figures 7A–G). Importantly, neurite
outgrowth was not altered by control siRNA (85.1 ± 5.6) (p >
0.05). CRMP2 siRNA-mediated reduction in neurite outgrowth
was recapitulated by overnight application of 200μM (S)-LCM,
which decreased total outgrowth by ∼34% compared to control
(66.2 ± 4.5) (p < 0.05) (Figures 7A–K). The effects of (S)-LCM
and CRMP2 siRNA appeared to mutually occlude one another
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FIGURE 3 | (S)-LCM binds to wildtype CRMP2 in solution measured by
microscale thermophoresis (MST). (A) Illustration of hydration shell
changes after small molecule [i.e., (S)-LCM] binding to a macromolecule. The
changes in the hydration shell properties are detected in the MST instrument.
(B) MST assay principle. The four stages in a thermophoresis experiment: (i)
initial state (all molecules are randomly distributed); (ii) infrared (IR) laser is
turned on, and thermophoresis commences; (iii) steady state flow while IR
laser is turned on; and (iv) equilibration to initial state by back-diffusion with IR
laser turned off. The green arrow represents the steady-state time point at
which the MST measurements were analyzed for the graphs shown in (D,G).
(C) MST time traces of concentrations of (S)-LCM ranging from 0.006 to
100μM. Increasing concentrations altered thermodiffusion of NT-647 labeled
CRMP2. (D) MST values were used to determine dissociation constant for
binding of (S)-LCM to wildtype CRMP2, apparent Kd = 1.5 ± 0.01μM; the
curve was fit with an r2 value of 0.76. (E) Stereo view of the binding site for
(S)-LCM within one monomer of the CRMP2 structure (Stenmark et al.,
2007; Wang et al., 2010b). (S)-LCM is shown in capped-sticks representation.
The amino acids mutated to alanines are indicated in green text. (F) MST
time traces of concentrations of (S)-LCM ranging from 0.006 to 100μM. MST
experiments were repeated using NT-647 labeled CRMP25ALA harboring
mutations in residues as indicated in (E). (G) No association could be
detected between (S)-LCM and CRMP25ALA. The data could not be fitted
with a curve (r2 = 0.09). A representative of range of data points obtained
from at least 3 measurements is shown.
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FIGURE 4 | (S)-LCM does not affect tubulin-CRMP2 binding. (A) 96-well
plates coated with 200 ng tubulin were incubated with increasing
concentrations of recombinant CRMP2 or heat-denatured CRMP2. The Y axis
displays the OD450 absorbance of the ELISA using CRMP2-specific antibodies.
CRMP2 bound to tubulin with half-saturation concentration of ∼607nM.
Binding of heat-denatured CRMP2 demonstrated non-saturable background
binding to tubulin. (B) Competitive binding assay revealed that (S)-LCM does
not abrogate the binding of CRMP2 to tubulin. For (A,B), all measurements
were performed in sextuplicate and error bars indicate standard error of the
mean. Most of the error bars are smaller than the symbols.
as (S)-LCM was not able to provide a further reduction follow-
ing CRMP2 knockdown [(71.3 ± 3.3) vs. (62.6 ± 4.5)] (p >
0.05) (see Figures 7A–G). Total outgrowth is a composite sum-
mary of the following parameters: number of branches, number
of processes, mean process length, and maximum process length
(Figures 7H–K), all of which, aside from mean process length,
were reduced by both (S)-LCM and CRMP2 siRNA, compared
to both control siRNA and no treatment. Combined treatment of
CRMP2 siRNA and (S)-LCM did not produce a further reduction
in any parameter (data not shown).
TARGETING CRMP2 PREVENTS ACTIVITY DEPENDENT NEURITE
OUTGROWTH
Previously, CRMP2 was identified to be involved in activity-
dependent neurite outgrowth of cerebellar granule cells (Tan
et al., 2013). Unlike other central neurons, cerebellar granule
cells require slightly depolarizing conditions for survival in vitro.
Therefore, it is difficult to generalize this finding to other neu-
ron populations within the central nervous system. As such,
it is not known if CRMP2 is involved in outgrowth induced
by depolarization in neurons where it is not necessary for sur-
vival. To determine the involvement of CRMP2 in activity-driven
neurite outgrowth, cortical neurons overexpressing EGFP were
exposed to 25mM KCl and maintained for 96 h to ascertain
the extent of activity dependent neurite outgrowth (Figure 8A).
Consistent with previous findings (Tan et al., 2013), chronic
depolarization with 25mM KCl led to a ∼43% increase in total
neurite outgrowth (143.1 ± 11.5) compared to control (100 ±
6.6) (Figure 8B–G). Notably, blockade of CRMP2-mediated neu-
rite outgrowth by (S)-LCM was sufficient to prevent activity
dependent growth induced by KCl (68.4 ± 3.8 vs. 61.7 ± 3.5)
(p > 0.05). As our earlier data demonstrated that (S)-LCM is not
affecting VGSC function in these neurons, these data suggest that
KCl-facilitated neurite outgrowth is dependent on CRMP2.
To determine the potential mechanism underlying CRMP2’s
role in KCl-facilitated neurite outgrowth, we examined the abil-
ity of CRMP2 to bind tubulin following chronic exposure to KCl
(Figure 9A). Lysates from cortical neurons that had been exposed
to KCl for 96 h were incubated on tubulin-coated plates. An
ELISA was then used to determine the amount of bound CRMP2.
Consistent with the notion that a loss of phosphorylation should
translate into an increase in CRMP2 activity, KCl exposure led to
a∼43.5% increase in the binding of CRMP2 to tubulin compared
to control (p < 0.05) (Figure 9B). As (S)-LCM was previously
demonstrated to alter CRMP2 function by inhibiting its ability
to enhance the intrinsic GTPase activity of tubulin, the addition
of (S)-LCM did not alter the effect of KCl on CRMP2/tubulin
binding [(143.5 ± 11.9) compared to KCl alone (133.5 ± 4.6)]
(p > 0.05) (Figure 9).
DISCUSSION
Our findings demonstrate that KCl-facilitated neurite outgrowth
in cultured cortical neurons is a CRMP2-dependent process.
Specifically, neuronal activity led to changes in CRMP2 activ-
ity through regulation of its phosphorylation state (Figure 10).
Interestingly, decreased levels of GSK3β-phosphorylated CRMP2
were observed following activity that were secondary, not to
changes in GSK3β expression or activity, but rather decreased
CRMP2 priming by Cdk5. CRMP2 has been suggested to be
involved in many processes with potential activity-dependent
components such as epilepsy, pain, and schizophrenia (Johnston-
Wilson et al., 2000; Nakata et al., 2003; Czech et al., 2004; Fallin
et al., 2005; Ryu et al., 2008; Brittain et al., 2011a; Wilson et al.,
2012a,b). These findings may provide key insight into the impor-
tance of CRMP2 within these neuropathologies. Previous work
in our lab suggested the potential anti-epileptogenic benefit of
targeting CRMP2-mediated neurite outgrowth following CNS
insult (Wilson et al., 2012a). The findings presented here fur-
ther validate CRMP2 as a potential therapeutic target in processes
involving maladaptive activity-dependent neurite outgrowth.
NEURONAL ACTIVITY ALTERS THE PHOSPHORYLATION STATE OF
CRMP2
Previous work revealed that phosphorylation of CRMP2 by
GSK3β is altered following chronic exposure to KCl in cere-
bellar granule cells (Tan et al., 2013). Here, we have demon-
strated that chronic activity led to decreased levels of GSK3β-
phosphorylated CRMP2 in primary cortical neurons as well.
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FIGURE 5 | (S)-LCM subverts CRMP2-mediated tubulin polymerization.
(A) Effects of enantiomers of LCM on CRMP2-mediated microtubule
assembly were measured by light scattering and absorbance at 412 nm. Also
shown is the basal tubulin self-polymerization in the absence of any additional
protein (no protein). Values represent measurements performed in triplicate.
Background absorbance was subtracted from each measurement. Values
from a representative experiment are illustrated. (B) Average area under the
curve values ± s.e.m. calculated from the tubulin polymerization curves
shown in (A). The addition of CRMP2 increased polymerization, while the
inclusion of 3μM (R)- or (S)-LCM led to a significant reduction in CRMP2-
mediated enhancement of tubulin polymerization AUC compared to DMSO
(∗p < 0.05; One-Way ANOVA, Bonferroni post-hoc analysis).
GSK3β phosphorylation of CRMP2 is potentially regulated by
two distinct mechanisms: (1) changes in GSK3β expression or
activity or (2) changes in substrate recognition. Like many sub-
strates, prior phosphorylation of CRMP2 by Cdk5 is required
for subsequent phosphorylation by GSK3β (Cole et al., 2006),
providing a level of regulation independent of GSK3β activity.
Our findings suggest that loss of Cdk5 priming is responsible for
the activity-driven decrease in GSK3β-phosphorylated CRMP2.
Interestingly, Cdk5 phosphorylation of CRMP2 displayed a time-
dependent decrease following KCl exposure while phosphoryla-
tion by GSK3β did not. It is possible that a ceiling effect on
GSK3β phosphorylation of CRMP2 was reached by the amount
of Cdk5 phosphorylation that was decreased after only 30min
of KCl exposure. Further reduction in Cdk5 phosphorylation of
CRMP2 would therefore not result in additional change in GSK3β
phosphorylation.
At this point, the mechanism underlying the change in Cdk5-
phosphorylated CRMP2 is unknown. As the Cdk5 site on CRMP2
(Ser522) has been shown to be resistant to dephosphorylation
(Cole et al., 2008), the involvement of protein phosphatases is
FIGURE 6 | (S)-LCM does not alter slow-inactivation of voltage-gated
sodium channels. (A) Voltage protocol for slow inactivation. Currents were
evoked by 5 s prepulses between−100 and+20mV and then fast-inactivated
channelswere allowed to recover for 5 s at a hyperpolarized pulse to−100mV.
The fraction of channels available was determined by a 15ms test pulse at
−10mV. (B) Representative peak Na+ currents, in response to a step to
−10mV following a prepulse at−100mV (black trace) and−50mV (gray trace)
in neurons in the absence (left) or presence (right) of 300μM (S)-LCM. (C)
Summary of steady-state slow inactivation curves fromcortical neurons in the
absence or presence of 300μM (S)-LCM applied acutely or overnight. (D) For
comparison, the fraction of current available following a −50mV prepulse is
depicted. (S)-LCM did not alter sodium channel steady-state slow inactivation
in cortical neurons at either time (p > 0.05) (Student’s t-test) (n = 6).
unlikely. Unfortunately, mechanisms by which the activity of
Cdk5 is regulated following neuronal activity are not well under-
stood. Work by Schuman and Murase suggests that neuronal
activity driven by KCl depolarization leads to a decrease in Cdk5
activity that is cofactor independent (Schuman and Murase,
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FIGURE 7 | The effect of (S)-LCM on neurite outgrowth phenocopies
siRNA knockdown of CRMP2. (A) Representative inverted black and white
representative image of a cortical neuron 48 h following EGFP-transfection.
(B–F) Representative tracings of neurons transfected with EGFP ± control
siRNA, CRMP2 siRNA, 200μM (S)-LCM, or CRMP2 siRNA + (S)-LCM. (G)
Total outgrowth of neurons transfected with EGFP, control siRNA, or
CRMPsiRNA combined with 24 h (S)-LCM treatment (200μM). CRMP2
siRNA and (S)-LCM reduced outgrowth to a similar level. Combination of
CRMP2 and (S)-LCM did not produce a further reduction. (H–K) Comparison
of the effects of CRMP2 siRNA and (S)-LCM on # of branches, # of
processes, mean process length, and maximum process length. (∗p < 0.05
vs. EGFP alone, One-Way ANOVA, Tukey’s post-hoc analysis) (values
represent mean ± s.e.m.) (n = 86–320 cells, 8 separate culture wells) (scale
bar = 50μm).
2003). This work has since been corroborated in a report from
the Bibb group that demonstrated activity-dependent decreases
in Cdk5 activity that were p35 independent (Nguyen et al.,
2007). Therefore, future work will seek to identify the events
linking neuronal activity to the changes in Cdk5 phosphorylation
observed in this study.
The ability of CRMP2 to mediate cytoskeletal dynamics is
highly dependent upon its phosphorylation state (for review see
Khanna et al., 2012). In this regard, unphosphorylated CRMP2
is considered active and growth-promoting whereby upon phos-
phorylation, it is rendered inactive. That CRMP2 is phosphory-
lated by numerous kinases allows for multiple signaling pathways
to converge on a single point, the balance of unphosphory-
lated (active) and phosphorylated (inactive) CRMP2. Changes
in kinase activity that alter this balance should thereby lead to
corresponding changes in CRMP2 activity. Therefore, it was not
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FIGURE 8 | Targeting CRMP2 prevents activity-dependent increase in
neurite outgrowth. (A) Timeline of experimental procedures. (B–E)
Representative tracings of cortical neurons expressing EGFP and incubated
for 96 h in vehicle, 25mM KCl, 200μM (S)-LCM, or 25mM KCl + 200μM
(S)-LCM. (F) Total outgrowth of cortical neurons exposed to 25mM KCl in the
presence or absence of 200μM (S)-LCM. (G) In naïve neurons, KCl exposure
increased outgrowth by ∼40% compared to vehicle. Co-application of
(S)-LCM blunted the KCl-induced increase to ∼10% (∗p < 0.05 compared to
control; Student’s t-test) (n = 110–379 cells, across 8 separate culture wells)
(scale bar = 50μm).
surprising that our findings revealed that the activity-dependent
reduction of CRMP2 phosphorylation directly translated into an
increase in binding between CRMP2 and tubulin.
(S)-LCM IS A VALUABLE TOOL FOR TARGETING CRMP2-MEDIATED
NEURITE OUTGROWTH IN EPILEPTOGENIC PROCESSES
Very few proteins can be considered truly unifunctional. The
ability to carry out multiple functions allows for varying levels
of dynamic regulation. A drawback of this cellular multitask-
ing is the difficulty in dissecting out specific functions. In the
case of CRMP2, the ability to regulate neurite outgrowth is
merely one facet of CRMP2 function and its study can be con-
founded by the role of CRMP2 in other processes such as synaptic
transmission (Brittain et al., 2009; Chi et al., 2009), excitotoxi-
city/neurodegeneration (Castegna et al., 2002; Cole et al., 2006;
Sultana et al., 2007; Brittain et al., 2011b, 2012), and migration
(Sun et al., 2010), among many others. Therefore, the identi-
fication of tools to parse out select functions is invaluable in
the dissection of CRMP2’s roles within the nervous system. Our
findings indicate that (S)-LCM can be used in place of genetic
knockdown strategies to preferentially study neurite outgrowth
mediated by CRMP2. Aside from a tool for the study of this
particular function of CRMP2, (S)-LCM may have therapeu-
tic potential for diseases in which aberrant neurite outgrowth
is known to contribute to the pathology. As more knowledge is
gained regarding the role of CRMP2-mediated neurite outgrowth
in various pathologies, the ability of (S)-LCM to abrogate this
phenomenon may prove extremely valuable.
Activity-dependent neurite outgrowth holds important impli-
cations for many pathological conditions, perhaps the most
apparent being epilepsy. Therefore, CRMP2 may prove a promis-
ing target for therapeutic intervention. Indeed, previous work
has demonstrated that targeting CRMP2 via (R)-LCM prevents
the aberrant increase in excitatory connectivity in an animal
model of posttraumatic epileptogenesis (Wilson et al., 2012a).
We also previously showed that following traumatic brain injury
(TBI), CRMP2 phosphorylation is decreased concomitantly with
increased mossy fiber sprouting in the hippocampus. This bio-
logical event is related to tubulin polymerization promoted by
non-phosphorylated, active CRMP2. Here, we demonstrate that
specific binding of (S)-LCM to CRMP2 results in an inhi-
bition of CRMP2-dependent tubulin polymerization in vitro
(Figure 5). Since (S)-LCM does not alter slow-inactivation of
VGSCs (Figure 6), this compound has fewer off-target effects
than its enantiomer parent compound (R)-LCM. This assertion is
further supported by the observations that (S)-LCM is more effi-
cient than (R)-LCM in inhibiting neurite outgrowth (Table 1), a
CRMP2-dependent event. Thus, we propose that (S)-LCM can be
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FIGURE 9 | Chronic KCl depolarization increases the association of
CRMP2 and tubulin. (A) Timeline of experimental procedures. (B)
Summary of CRMP2-binding to tubulin from cortical cell lysates as
determined by ELISA. The values obtained from these experiments are
arbitrary optical densities. Thus, we have normalized the values of treated
groups to the control group, which was set to 100%. This allows us to
compare values across experiments. KCl exposure increased CRMP2
binding by ∼43.5% compared to control. As (S)-LCM was previously shown
not to impact CRMP2/tubulin binding, its co-application did not alter the
effect of KCl. (∗p < 0.05 compared to control; One-Way ANOVA, Tukey’s
post-hoc analysis) (n = 4).
FIGURE 10 | Working model for CRMP2-mediated, activity-dependent
increase in neurite outgrowth and preferential inhibition by (S)-LCM. In
control neurons (black arrows), CRMP2-mediated neurite outgrowth is
driven by the binding of CRMP2 and tubulin, as well as, the enhancement
of tubulin polymerization. Phosphorylation of CRMP2 by GSK3β and/or
Cdk5 impairs its binding to tubulin, leading to neurite outgrowth arrest.
Neuronal activity driven by KCl depolarization (blue arrows) leads to reduced
priming by Cdk5 (residue S522), which prevents subsequent
phosphorylation by GSK3β (residues T509/T514/S518; latter residue not
shown). This transition to the unphosphorylated form results in increased
binding of CRMP2/tubulin and CRMP2-dependent tubulin polymerization,
thereby increasing neurite outgrowth. (S)-Lacosamide (green arrows)
interacts with CRMP2 to directly impair its GAP activity, thus preventing the
enhancement of tubulin polymerization and, therefore, neurite outgrowth
(arrow size denotes the effect of treatment, i.e., increases in size imply a
positive effect and decreases in size imply a negative effect).
a molecule of particular interest in targeting aberrant CRMP2-
mediated neurite outgrowth in epileptogenesis. As a proof-of-
concept, we previously demonstrated that (S)-LCM treatment, in
a TBI animal model, resulted in a complete inhibition of mossy
fiber sprouting compared to sham control animals (Wilson et al.,
2014).
While the action of (S)-LCM is likely mediated by its ability to
impair the enhancement of tubulin polymerization by CRMP2,
the effect of (S)-LCM on every function of CRMP2 remains
untested. At this time, (S)-LCM does not appear to alter tubulin
binding nor synaptic bouton size. Additionally, the parent com-
pound (R)-LCM also has no effect on these processes, as well as
calcium channel trafficking or glutamate release (Wilson et al.,
2012a)—processes altered by changes in CRMP2 function.
ACTIVITY-DRIVEN NEURITE OUTGROWTH IN CULTURED CORTICAL
NEURONS IS A CRMP2-DEPENDENT PROCESS, MEDIATED BY
CHANGES IN PHOSPHORYLATION STATE
Consistent with the observed changes in CRMP2 phosphory-
lation and tubulin binding, inhibition of CRMP2 by (S)-LCM
prevented the activity-driven increase in neurite outgrowth. As
previously mentioned, CRMP2 is capable of mediating neurite
outgrowth through two distinct mechanisms: (1) the binding
and transport of tubulin dimers (Fukata et al., 2002) and (2)
enhancement of the GTPase activity and, therefore, polymeriza-
tion of tubulin (Chae et al., 2009). While the impact of neuronal
activity on the ability of CRMP2 to enhance tubulin polymeriza-
tion is unknown, our results suggest that an increased association
with tubulin accounts for the increase in CRMP2-mediated neu-
rite outgrowth. The ability of (S)-LCM to preclude the effect
of KCl on neurite outgrowth lies not within preventing the
KCl-facilitated increase in tubulin binding, but rather via simul-
taneously impairing the ability of CRMP2 to promote tubulin
polymerization. This data suggests that the CRMP2’s inability to
enhance tubulin’s GTPase activity, may overrule an increase in
affinity for tubulin. Nevertheless, our findings do not rule out the
possibility that (S)-LCM’s full mechanism of action may include
inhibition or enhancement of CRMP2 binding with unknown
partner protein(s). Our findings (Figure 10), along with those of
Tan et al. (2013), represent two separate reports of the involve-
ment of CRMP2 in activity-driven neurite outgrowth in two
distinct cell populations.
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